Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004561-34Phase 4Active
Phase 4 trial of tranexamic acid in aortic valve disease (AVD), coronary arteriosclerosis and postoperative hemorrhage, sponsored by St. Olavs University Hospital. Primary endpoints: Postoperative bleeding, Postoperative hemoglobin loss and 2 more. Started Sep 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004561-34.